|
Lopez-Galvez R, Rivera-Caravaca JM, Anguita Sanchez M, Sanmartin Fernandez M, Rafols C, Perez-Cabeza AI, Baron Esquivias G, Lekuona Goya I, Vazquez Rodriguez JM, Cosin Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marin F. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study. Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14. PubMed PMID: 35395094.
AÑO: 2022; IF: 5.5
|
35395094
|
Garcia-Tudela A, Simonelli-Munoz AJ, Rivera-Caravaca JM, Fortea MI, Simon-Sanchez L, Gonzalez-Moro MTR, Gonzalez-Moro JMR, Jimenez-Rodriguez D, Gallego-Gomez JI. Stress in Emergency Healthcare Professionals: The Stress Factors and Manifestations Scale. Int J Environ Res Public Health. 2022 Apr 5;19(7):4342. doi: 10.3390/ijerph19074342. PubMed PMID: 35410024; PubMed Central PMCID: PMC8998299.
AÑO: 2022; IF: 4.614
|
|
Rivera-Caravaca JM, Roldan V, Martinez-Montesinos L, Vicente V, Lip GYH, Marin F. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. J Gen Intern Med. 2023 Feb;38(2):315-323. doi: 10.1007/s11606-022-07567-5. Epub 2022 Apr 11. PubMed PMID: 35411538; PubMed Central PMCID: PMC9905403.
AÑO: 2023; IF: 4.3
|
|
Lopez-Galvez R, Marin F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J. 2022 Sep;251:32-34. doi: 10.1016/j.ahj.2022.05.007. Epub 2022 May 7. No abstract available. PubMed PMID: 35537504.
AÑO: 2022; IF: 4.8
|
|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|